So we focused on early-phase clinical trials. And one of the main barriers that we saw to that was a lack of availability of trials. On top of Canada being a very large country with many hours in between centers. And our early-phase clinical trials are really focused at certain centers. So there was sometimes a lack of access for other patients or it meant traveling or it meant a cost to the family...
So we focused on early-phase clinical trials. And one of the main barriers that we saw to that was a lack of availability of trials. On top of Canada being a very large country with many hours in between centers. And our early-phase clinical trials are really focused at certain centers. So there was sometimes a lack of access for other patients or it meant traveling or it meant a cost to the family. So these are important things to keep in mind and looking for ways to overcome that. So is that more trials being at more centers? Is that offering supports to patients and families so they can access trials that are at other centers? And is it about the centers getting together and perhaps creating more satellite models from the main hubs?
This transcript is AI-generated. While we strive for accuracy, please verify this copy with the video.
